Immune cell therapy shows promise for hard-to-treat ovarian cancers

This early-phase study tested a new treatment for women with ovarian, fallopian tube, or peritoneal cancer that returned or didn't respond to standard therapy. The approach involved taking a type of white blood cell (monocytes) from each participant, activating them with immune-boosting drugs, and infusing them back into the abdomen. The goal was to see if this combination could safely shrink tumors or slow cancer growth. The study was terminated early, but results help guide future research.